Replies to post #347114 on Amarin Corp Plc (AMRN)

[Invest83838]

Raf, More Weekly Proof that JT was a great CEO

NOT!

[Number sleven]

Raf, Thanks for the numbers.
Sleven,

[ralphey]

V's decline was the least so I guess that good - is this the off week for gV ?

[Rob777]

Rafunrafun- Appreciate you doing this every week! I thought today's were encouraging for a lot of reasons. The sales department needs to do better though. There is still a lot of value in the US market.

[MNBioMike]

40,000 mother effing hours. What is the sales team doing with 40k hours. That’s a ton of time dedicated to one drug, no others.

What the serious fu@k…..

[oneragman]

raf, 2 weeks in a row we gained, not lost market share. Not enough for a trend yet, but encouraging. Hopefully a sign that formulary changes will boost the numbers.

[rafunrafun]

Scripts for week ending July 16, 2021

Overall drug TRx are +5.6% w/w.

Vascepa
TRx 85,304; +7.1% (+5,662) w/w; -2.8% y/y
NRx 38,018; +10.7% (+2, 697) w/w; -6.6% y/y
Ref 47,286; +4.4% (+1,997) w/w; +0.6% y/y

Lovaza (Generic & Brand)
TRx 63,466; +6.5% (+3,847) w/w; +1.8% y/y
NRx 31,238; +13.3% (+3,670) w/w; +3.6% y/y
Ref 32,228; +0.6% (+176) w/w; +0.0% y/y

Generic Vascepa
TRx 14,355; +20.8% (+2,470) w/w; As % of total V: 14.4%
NRx 8,122; +22.4% (+1,485) w/w; As % of total V: 16.2%
Ref 6,233; +18.8% (+986) w/w; As % of total V: 11.6%

Generic Vascepa by Manufacturer
Hikma TRx 11,158; Generic share 77.7%; Total V share 11.2%
Reddy TRx 3,197; Generic share 22.3%; Total V share 3.2%